MANE · Veradermics, Inc · Exempt Offerings
$119.00
+0.13 (+0.11%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Update ("ASU") 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. ... As of June 30, 2026, we had $819.9 million in cash, cash equivalents and marketable securities. We expect our existing cash, cash equivalents and marketable securities will enable the Company to meet its obligations for at least the twelve-month period from the date the financial statements are available to be issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$4.87B
Shares
41.78M
Volume · Oct 5
536.36K
Avg daily vol (3M)
717.4K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-15 | New | Other Health Care | $29,999,997 | $29,999,997 | 06b |
| 2025-10-28 | New | Other Health Care | $149,999,978 | $134,999,978 | 06b |
| 2024-12-10 | New | Other Health Care | $75,000,000 | $66,567,075 | 06b |
| 2023-05-01 | New | Other Health Care | $15,000,000 | $15,000,000 | 06b |
| 2021-10-07 | Amendment | Other Health Care | $22,238,328 | $22,238,328 | 06b |
| 2021-10-06 | New | Other Health Care | $22,238,328 | $22,238,328 | 06b |
| 2020-10-09 | New | Other Health Care | $1,500,000 | $476,100 | 06b |
Showing 1–7 of 7 filings